Sandoz acquires Fougera Pharmaceuticals
Sandoz has completed its USD 1.525 billion acquisition of specialty US dermatology company Fougera Pharmaceuticals on a cash and debt free basis.
Original Article: Sandoz acquires Fougera Pharmaceuticals
NEXT ARTICLE